| Catalog Number |
03P77-25 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Information (3190)
|
| Date of Event |
11/15/2016
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
(b)(4).Apoc labeling was evaluated during the investigation as pertaining to the event.The investigation was completed on 01/31/2017.Retain product was tested and functioning according to specification.Return product was not available for investigation.Investigation: a review of the device history record (dhr) confirmed that the cartridge lot met finished goods (fg) release criteria.Retained cartridge testing met the acceptance criteria outlined in q04.01.003 rev.Z, appendix 1- product complaint level 2 and level 3 investigation procedure.Customer complaint was not reproduced.Assessment: the complaint investigation concluded there was no product deficiency and that the i-stat cartridge lot is meeting specification.There are no repeats on the i-stat.The i-stat was reported as > 9 and the laboratory was reported on normal, with no specific value provided.Results for potassium are affected by the amount of time the sample is allowed to stand before testing, hemolysis, sample type (serum versus plasma) and interfering substances (bromide, sodium thiosulfate).There is not enough information to determine whether an i-stat product malfunction occurred.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2016, abbott point of care was contacted by a customer regarding i-stat eg6+ cartridges that yielded suspected discrepant potassium (k) result on a patient.There were no injuries associated with this event.There was no additional patient information available at the time of this report.Return product is not available for investigation.Method: i-stat, test time: unk, k: >9.0.Results lab: normal (a precise result is not available).Follow up testing was done in the lab.Results lab: normal (a precise result is not available).At the time of the event there was no indication of a product malfunction based on the information provided and assessed by apoc, however this mdr is a retrospective filing in response to an observation from an fda inspection conducted may 8th to 12th, 2017 at abbott point of care (b)(4).
|
| |
|
Search Alerts/Recalls
|